Treatment of M.Graves With Radioactive Iodine: Follow-up Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Medisch Centrum Rijnmond-Zuid, Netherlands.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Medisch Centrum Rijnmond-Zuid, Netherlands
ClinicalTrials.gov Identifier:
NCT00525122
First received: September 4, 2007
Last updated: May 21, 2008
Last verified: May 2008
  Purpose

Hypothesis: What is the natural course after treatment with radioactive iodine in patients with hyperthyroidism?

What are the determinants for the development of acute hypo- or hyperthyroidism after treatment with radioactive iodine without antithyroid drugs?


Condition
Hyperthyroidism

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Medisch Centrum Rijnmond-Zuid, Netherlands:

Estimated Enrollment: 100
Study Start Date: September 2007
Groups/Cohorts
1
Patients with hyperthyroidism who are will be treated with radioactive iodine.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients of 18 years and older with hyperthyroidism who are eligible for treatment with radioactive iodine.

Criteria

Inclusion Criteria:

  • Patients wth hyperthyroidism who are eligible for treatment with radioactive iodine
  • Age > 18 years

Exclusion Criteria:

  • Severe ophthalmopathy
  • Pregnancy or wish to pregnancy on short term
  • Breastfeeding
  • Patients already treated with radioactive iodine
  • Known cardiovascular diseases or other severe comorbidity
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00525122

Contacts
Contact: A. Berghout, MD, PhD 0031 10 2913368 BerghoutA@mcrz.nl

Locations
Netherlands
MCRZ Recruiting
Rotterdam, Zuid-Holland, Netherlands, 3075 EA
Contact: A Berghout, MD, PhD         
Sponsors and Collaborators
Medisch Centrum Rijnmond-Zuid, Netherlands
Investigators
Principal Investigator: A. Berghout, MD, PhD Medisch Centrum Rijnmond-Zuid, Netherlands
Principal Investigator: C. van Noord, MD Medisch Centrum Rijnmond-Zuid, Netherlands
  More Information

No publications provided

Responsible Party: A. Berghout, MCRZ
ClinicalTrials.gov Identifier: NCT00525122     History of Changes
Other Study ID Numbers: 2006/60
Study First Received: September 4, 2007
Last Updated: May 21, 2008
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Medisch Centrum Rijnmond-Zuid, Netherlands:
hyperthyroidism
radioactive iodine
antithyroid drugs
Hyperthyroidism, treatment with radioactive iodine without antithyroid drugs

Additional relevant MeSH terms:
Hyperthyroidism
Thyroid Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on September 22, 2014